CROTTI, LIA
 Distribuzione geografica
Continente #
NA - Nord America 11.259
EU - Europa 5.127
AS - Asia 2.829
SA - Sud America 77
OC - Oceania 28
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 7
Totale 19.346
Nazione #
US - Stati Uniti d'America 11.133
IT - Italia 1.156
SG - Singapore 1.100
CN - Cina 949
IE - Irlanda 866
RU - Federazione Russa 803
SE - Svezia 688
DE - Germania 514
HK - Hong Kong 448
GB - Regno Unito 337
UA - Ucraina 197
CA - Canada 117
FR - Francia 111
ID - Indonesia 80
ES - Italia 75
JP - Giappone 64
NL - Olanda 63
AT - Austria 52
IN - India 51
DK - Danimarca 50
VN - Vietnam 49
FI - Finlandia 48
BE - Belgio 36
BR - Brasile 35
CH - Svizzera 32
GR - Grecia 21
AU - Australia 20
TR - Turchia 17
AR - Argentina 16
PT - Portogallo 16
PL - Polonia 12
RO - Romania 12
CO - Colombia 11
CL - Cile 10
IR - Iran 8
MX - Messico 8
NZ - Nuova Zelanda 8
SC - Seychelles 7
HR - Croazia 6
IL - Israele 6
RS - Serbia 6
SA - Arabia Saudita 6
CZ - Repubblica Ceca 5
KW - Kuwait 5
KZ - Kazakistan 5
MY - Malesia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
BD - Bangladesh 4
KR - Corea 4
NO - Norvegia 4
TH - Thailandia 4
BG - Bulgaria 3
CY - Cipro 3
DZ - Algeria 3
EU - Europa 3
HU - Ungheria 3
LK - Sri Lanka 3
SI - Slovenia 3
TW - Taiwan 3
AM - Armenia 2
BY - Bielorussia 2
EG - Egitto 2
ET - Etiopia 2
LT - Lituania 2
MT - Malta 2
OM - Oman 2
PK - Pakistan 2
PY - Paraguay 2
BO - Bolivia 1
EC - Ecuador 1
IQ - Iraq 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 19.346
Città #
Fairfield 1.558
Ann Arbor 1.273
Singapore 939
Dublin 814
Chandler 740
Woodbridge 698
Ashburn 697
Wilmington 674
Houston 595
Seattle 563
Dearborn 501
Cambridge 492
Hong Kong 431
Frankfurt am Main 420
New York 419
Princeton 363
Milan 343
Santa Clara 247
Nanjing 167
Lawrence 161
Jacksonville 153
Altamura 152
San Diego 103
Beijing 96
Jakarta 79
London 69
Shenyang 61
Hebei 60
Andover 57
Guangzhou 56
Nanchang 55
Toronto 54
Rome 53
Jinan 52
Shanghai 52
Vienna 49
Helsinki 38
Zhengzhou 36
Dong Ket 35
Boardman 33
Tianjin 33
Jiaxing 32
Changsha 28
Norwalk 28
Ottawa 26
Phoenix 26
São Paulo 23
Hangzhou 22
Ningbo 22
Tokyo 22
Chicago 21
Amsterdam 18
Brussels 17
Castano Primo 17
Hefei 17
Los Angeles 17
Madrid 15
Groningen 13
Kunming 13
San Francisco 13
Upper Marlboro 13
Verona 13
Central 12
Pavia 12
Pune 12
Clearwater 11
Edmonton 11
Washington 11
Falls Church 10
Florence 10
Huizen 10
Moscow 10
Redmond 10
Voghera 10
Wuhan 10
Zurich 10
Athens 9
Mountain View 9
Taizhou 9
Turin 9
Fremont 8
Atlanta 7
Bari 7
Bogotá 7
Cincinnati 7
Copenhagen 7
Desio 7
Kilburn 7
Lecce 7
Liège 7
Naples 7
Alicante 6
Buenos Aires 6
Edinburgh 6
Esplugues de Llobregat 6
Fuzhou 6
Girona 6
Kiev 6
Lambeth 6
Lappeenranta 6
Totale 14.204
Nome #
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 352
Indications and utility of cardiac genetic testing in athletes 341
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young 318
International Triadin Knockout Syndrome Registry: The Clinical Phenotype and Treatment Outcomes of Patients with Triadin Knockout Syndrome 307
NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis 268
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 268
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 241
Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes 236
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 210
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 203
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 202
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 197
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome 188
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 185
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 182
Investigation on Sudden Unexpected Death in the Young (SUDY) in Europe: results of the European Heart Rhythm Association Survey 171
Long QT Syndrome and Brugada Syndrome : 2 aspects of the same disease? 157
Mapping the human genetic architecture of COVID-19 157
Partial Pericardial Agenesis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy 155
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 149
Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome. 148
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche [Clinical conditions associated with abnormal QT interval: clinical implications] 147
Exercise Training-Induced Repolarization Abnormalities Masquerading as Congenital Long QT Syndrome 146
Biventricular arrhythmogenic cardiomyopathy: a paradigmatic case. 142
Infanticide vs. inherited cardiac arrhythmias. 139
The ICD for the long QT syndrome: which indications, complications, and results? 137
Response by Crotti et al to Letter Regarding Article, "genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1?" 133
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents 133
Inherited cardiac arrhythmia syndrome. Role of potassium channels 131
Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation? 127
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 126
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 126
Brugada and Long QT Syndrome are two different diseases: True or False? 126
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 126
The Common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification 125
A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK) 124
Prevalence of the congenital long-qt syndrome 123
Long and Short QT syndromes. 121
Calmodulin mutations and life-threatening cardiac arrhythmias: Insights from the International Calmodulinopathy Registry 121
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 121
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1 120
The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome 120
Mutation-Specific Risk in Two Genetic Forms of Type 3 Long QT Syndrome 119
Cardiac potassium channel dysfunction in sudden infant death syndrome 119
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1 119
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population 118
Response to Letters Regarding Article, "clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 117
The role of genetics in primary ventricular fibrillation, inherited channelopathies and cardiomyopathies 116
The genetics underlying acquired long QT syndrome: Impact for genetic screening 116
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge 116
An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition 116
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome 115
Neuroimmune crosstalk in the pathophysiology of hypertension. 115
AKAP9 is a genetic modifier of congenital long-QT syndrome type 1 114
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms 114
Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families 114
The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia? 114
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroups. 114
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5 113
Gain of function mutation, S422L, in the KCNJ8-encoded cardiac K ATP channel Kir6.1 as a pathogenic substrate for J wave syndromes 113
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome 113
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients 112
Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies 112
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation 112
The Long QT Syndrome 112
Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions -A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology 111
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome 111
A refined multiscale self-entropy approach for the assessment of cardiac control complexity: Application to long QT syndrome type 1 patients 110
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis 110
Long and Short QT Syndromes 110
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome 109
Genetic of adult and fetal forms of Long QT Syndrome. 108
To be, or not to be engaged in sport activities, that is the amletic question for patients with coronary artery disease 108
Cardiac sodium channel dysfunction in sudden infant death syndrome 107
Congenital long QT syndrome 107
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome 106
Founder populations with channelopathies and church records reveal all sorts of interesting secrets: Some are scientifically relevant 106
Low-pass filtering approach via empirical mode decomposition improves short scale entropy-based complexity estimation of QT interval variability in Long QT Syndrome Type 1 patients 105
Clinical Implications for Patients With Long QT Syndrome Who Experience a Cardiac Event During Infancy 105
A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: Validation of the 2013 diagnostic criteria 104
QTc behavior during exercise and genetic testing for the long-QT syndrome 104
Time, frequency and information domain analysis of heart period and QT variability in asymptomatic long QT syndrome type 2 patients 103
Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia 102
Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations 101
Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry 101
All LQT3 patients need an ICD. True or false? 100
Sudden cardiac death in infancy: Focus on prolonged repolarization 99
Reply to the Editor--Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients 98
Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes 98
Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel 98
Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome 98
Ion channel diseases in children: Manifestations and management 98
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome 96
When genetic screening for your patient with long QT syndrome comes back negative, don't always take a no for a no 96
Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol 95
Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization 94
Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors 94
Gene expression and arrhythmic risk 93
Abnormal myocardial expression of SAP97 is associated with arrhythmogenic risk 92
NOS1AP is a genetic modifier of the long-QT syndrome 91
Totale 13.560
Categoria #
all - tutte 84.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.849


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.714 0 0 0 347 318 537 467 342 305 179 136 83
2020/20212.916 68 202 293 297 168 264 543 300 182 231 181 187
2021/20221.909 153 163 235 85 61 117 117 152 95 208 221 302
2022/20233.996 425 913 301 350 274 652 92 261 354 65 169 140
2023/20243.086 124 162 157 89 420 709 509 107 300 92 79 338
2024/20252.523 466 1.208 617 232 0 0 0 0 0 0 0 0
Totale 20.493